This report presents a comprehensive overview of the Stem Cell Banking market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Stem Cell Banking industry.
This report focuses Global and Europe market, including details as following:
China Cord Blood Corporation (China)
CBR Systems, Inc. (U.S.)
Boyalife Group (China)
RMS Regrow (Korea)
Cordlife Group (Singapore)
PBKM FamiCord (Switzerland)
Cellsafe Biotech Group (Malaysia)
Cryo Stemcell (India)
Stemade Biotech (India)
Asia & Pacific
Africa & Middle East
Key Product Type
By Bank Type: Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell.
By Service: Collection & Transportation, Analysis, Processing, Storage.